Informe del mercado de suministros para ensayos clínicos por servicio (fabricación de productos, envasado, etiquetado y almacenamiento, logística y distribución), fase (fase I, fase II, fase III y otros), área terapéutica (oncología, enfermedades cardiovasculares, enfermedades respiratorias, sistema nervioso central (SNC) y trastornos mentales y otros), industria de uso final (industria de dispositivos médicos, industria biofarmacéutica, industria farmacéutica y otros) y región 2024-2032

Informe del mercado de suministros para ensayos clínicos por servicio (fabricación de productos, envasado, etiquetado y almacenamiento, logística y distribución), fase (fase I, fase II, fase III y otros), área terapéutica (oncología, enfermedades cardiovasculares, enfermedades respiratorias, sistema nervioso central (SNC) y trastornos mentales y otros), industria de uso final (industria de dispositivos médicos, industria biofarmacéutica, industria farmacéutica y otros) y región 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A14981
Buy Now

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Clinical Trial Supplies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Services
    6.1    Product Manufacturing
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Packaging, Labeling and Storage
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Logistics and Distribution
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Phase
    7.1    Phase I
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Phase II
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Phase III
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Therapeutic Area
    8.1    Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cardiovascular Diseases
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Respiratory Diseases 
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    CNS and Mental Disorders
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others 
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by End-Use Industry
    9.1    Medical Device Industry
        9.1.1 Market Trends
        9.1.3 Market Forecast
    9.2    Biopharmaceuticals Industry
        9.2.1 Market Trends
        9.2.3 Market Forecast
    9.3    Pharmaceuticals Industry
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.3 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Almac Group Ltd.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Catalent Pharma Solutions Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    DHL
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Parexel
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 SWOT Analysis
        14.3.5    Thermo Fisher Scientific Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    PCI Services
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
        14.3.7    Sharp Clinical
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
        14.3.8    Biocair 
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 Financials
        14.3.9    Movianto
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 

Informe del mercado de suministros para ensayos clínicos por servicio (fabricación de productos, envasado, etiquetado y almacenamiento, logística y distribución), fase (fase I, fase II, fase III y otros), área terapéutica (oncología, enfermedades cardiovasculares, enfermedades respiratorias, sistema nervioso central (SNC) y trastornos mentales y otros), industria de uso final (industria de dispositivos médicos, industria biofarmacéutica, industria farmacéutica y otros) y región 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More